CD分類ハンドブック(2000) 改訂IV版

出版社: 癌と化学療法社
著者:
発行日: 2003-11-20
分野: 基礎・関連科学  >  細胞/細胞工学
ISBN: 4906225381
電子書籍版: 2003-11-20 (改訂第Ⅳ版第1刷)
書籍・雑誌
≪全国送料無料でお届け≫
品切れ

9,900 円(税込)

電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

4,950 円(税込)

商品紹介

モノクローナル抗体を一つのカテゴリーに分類整理し,国際的統一を図ったCD分類の最新ハンドブックである。ますます多岐にわたり膨大化するCD分類にあって,本書は、研究・臨床の場での座右の書である。

目次

  • CD分類ハンドブック(2000) 改訂IV版

    ―目次―

    推薦のことば

    本書の特色と利用法
    CD分類と必要性と意義
     1.CD分類の必要性と意義
     2.モノクローナル抗体の臨床への応用
    国際ワークショップの歴史
     1.第1回国際ワークショップ(パリ、1982年)
     2.第2回国際ワークショップ(ボストン、1984年)
     3.第3回国際ワークショップ(オックスフォード、1986年)
     4.第4回国際ワークショップ(ウィーン、1989年)
     5.第5回国際ワークショップ(ボストン、1993年)
     6.第6回国際ワークショップ(神戸、1996年)
     7.第7回国際ワークショップ(ハロゲイド、2001年
     8.第8回国際ワークショップ(アデレード、2004年開催予定)
    CD分類の成り立ち
     1.モノクローナル抗体の評価法
     2.モノクローナル抗体が結合するエピトープの局在
     3.CD分類の命名法と語句に関する知識
     4.膜分子の働き
     5.CD分類の系列分類
     6.CD分類の意味と論文での記載法
    最新のCD分類(第7回HLDA)の概要
    CD分類の成り立ち項目別解説
     1.CD分類の項目別解説
     2.モノクローナル抗体の索引
     3.細胞系列からみたCD分類
     4.各CD分類に関する主要文献リストとインターネット検索
     5.参考文献(Leucocyte typing?〜?)
    CD分類の項目別解説
    略語一覧
    索引

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

VI. CD分類の項目別解説と略語-一覧表と索引集について-

P.42 掲載の参考文献
・Leucocyte Typing VII, edited by Mason, D. et al, Oxford University Press, Oxford, 2002.
・Leucocyte Typing VI, edited by Kishimoto, T. et al, Garland Publishing Inc., New York, 1998.
・Leucocyte Typing V, edited by Schlossman, S. F. et al, Oxford University Press, Oxford, 1995.
・Leucocyte Typing IV, edited by Knapp, W. et al, Oxford University Press, Oxford, 1989.
・Leucocyte Typing III, edited by McMichael, A. J. et al, Oxford University Press, Oxford, 1987.

VII. CD分類の項目別解説

P.47 掲載の参考文献
2) Calabi F, Yung Yu C, Bilsland CAG, Milstein C:In Immunogenetics of the mayor histocompatibility complex De, (eds Srivastava R, Ram B, Tyle P), VCH Publishers, New York, pp215-243, 1991.
4) Melian A, Beckman EM, Porcelli SA, Brenner MB:Antigen presentation by CD1 and MHC-encoded class I-like molecules. Curr Opin Immunol 8:82, 1996.
8) Salamone MC, Roisman FR, Santiago J, Satz ML, Fainboim L:Analysis of CD1 molecules on haematological malignancies of myeloid and lymphoid origin. I. Cell surface antigen expression. Dis Markers 8:265, 1990.
10) Yu CY, Milstein C:A physical map linking the five CD1 human thymocyte differentiation antigen genes. EMBO J 8:3727, 1989.
P.48 掲載の参考文献
6) Jayawardena-Wolf J, Benlagha K, Chiu Y-H, Mehr R, Bendelac A:CD1d endosomal trafficking is independently regulated by an intrinsic CD1d-encoded tyrosine motif and by the invariant chain. Immunity 15:897-908, 2001.
15) Zeng Z-H, Castano AR, Segelke BW, Stura EA, Peterson PA, Wilson IA:Crystal structure of mouse CD1:an MHC-like fold with a large hydrophobic binding groove. Science 277:339-345, 1997.
P.50 掲載の参考文献
1) Albertson DG, Fishpool R, Sherrington P, Nacheva E, Milstein C:Sensitive and high resolution in situ hybridization to human chromosomes using biotin labelled probes:assignment of the human thymocyte CD1 antigen genes to chromosome 1. EMBO J 7:2801-2805, 1988.
3) Yu CY, Milstein C:A physical map linking the five CD1 human thymocyte differentiation antigen genes. EMBO J 8:3727-3732, 1989.
P.52 掲載の参考文献
1) Bell GM, Imboden JB:CD2 and the regulation of T cell anergy. J Immunol 155:2805, 1995.
4) Arulanandam AR, Moingeon P, Concino MF, Recny MA, Kato K, Yagita H, Koyasu S, Reinherz EL:A soluble multimeric recombinant CD2 protein identifies CD48 as a low affinity ligand for human CD2:divergence of CD2 ligands during the evolution of humans and mice. J Exp Med 177:1439, 1993.
5) Aversa GG, Bishop GA, Suranyi MG, Hall BM:RPA-2.10:an anti-CD2 monoclonal antibody that inhibits alloimmune responses and monitors T cell activation. Transplant Proc 19:277, 1987.
9) Filatov AV, Bachurin PS, Markova NA, Surnakova NE:Apanel of monoclonal antibodies against human lymphocyte antigens. Eksp Onkol 11:28, 1989.
11) Kato K, Koyanagi M, Okada H, Takanashi T, Wong YW, Williams AF, Okumura K, Yagita H:CD48 is a counter-receptor for mouse CD2 and is involved in T cell activation. J Exp Med 176:1241, 1992.
13) Warren HS, Altin JG, Waldron JC, Kinnear BF, Parish CR:A carbohydrate structure associated with CD15 (Lewis x) on myeloid cells is a novel ligand for human CD2. J Immunol 156:2866, 1996.
P.56 掲載の参考文献
P.57 掲載の参考文献
8) Thoenes G, Soudais C, le Deist F, Griscelli C, Fischer A, Lisowska-Grospierre B:Structural analysis of low TCR-CD3 complex expression in T cells of an immunodeficient patient. J Biol Chem 267 (1):487-493, 1992.
P.59 掲載の参考文献
2) Gaubin M, Autiero M, Houlgatte R, Basmaciogullari S, Auffray C, Piatier-Tonneau D:Molecular basis of T lymphocyte CD4 antigen functions. Eur J Clin Chem Clin Biochem 34:723, 1996.
8) Moir S, Perreault J, Poulin L:Postbinding events mediated by human immunodeficiency virus type 1 are sensitive to modifications in the D4-transmembrane linker region of CD4. J Virol 70:8019, 1996.
P.62 掲載の参考文献
1) Kipps TJ:The CD5 B cell. Adv Immunol 47:117, 1988.
2) Resnick D, Pearson A, Krieger M:The SRCR superfamily:a family reminiscent of the Ig superfamily. Trends Biochem Sci 19:5, 1993.
3) Alberola-Ila J, Places L, Cantrell DA, Vives J, Lozano F:Intracellular events involved in CD5-induced human T cell activation and proliferation. J Immunol 148:1287, 1992.
4) Alberola-Ila J, Places L, Lozano F, Vives J:Association of an activation inducible serine kinase activity with CD5. J Immunol 151:4423, 1993.
9) Bierer BE, Burakoff SJ, Smith BR:A large proportion of T lymphocytes lack CD5 expression after bone marrow transplantation. Blood 73:1359, 1989.
12) Ceuppens JL, Baroja ML:Monoclonal antibodies to the CD5 antigen can provide the necessary second signal for activation of isolated resting T cells by solid-phase bound OKT3. J Immzanol 137:1816, 1986.
15) Gary-Gouy H, Lang V, Sarun S, Boumsell L, Bismuth G:In vivo association of CD5 with tyrosine-phosphorylated ZAP-70 and p21 phospho-zeta molecules in human CD3+thymocytes. J Immunol 159:3739, 1997.
21) Reinherz EL, Kung PC, Goldstein G, Schlossman SF:Amonoclonal antibody with selective reactivity with functionally mature human thymocytes and all peripheral human T cells. J Immunol 123:1312, 1979.
P.64 掲載の参考文献
3) Bowen MA, Patel DD, Li X, Modrell B, Malacko AR, Wang WC, Marquardt H, Neubauer M, Pesando JM, Francke U, et al:Cloning, mapping, and characterization of activated leukocyte-cell adhesion molecule (ALCAM), a CD6 ligand. J Exp Med 181:2213, 1995.
4) Bowen MA, Whitney GS, Neubauer M, Starling GC, Palmer D, Zhang J, Nowak NJ, Shows TB, Aruffo A:Structure and chromosomal location of the human CD6 gene:detection of five human CD6 isoforms. J Immunol 158:1149, 1997.
5) Gangemi RM, Swack JA, Gaviria DM, Romain PL:Anti-T12, an anti-CD6 monoclonal antibody, can activate human T lymphocytes. J Immunol 143:2439, 1989.
6) Patel DD, Wee SF, Whichard LP, Bowen MA, Pesando JM, Aruffo A, Haynes BF:Identification and characterization of a 100-kD Iigand for CD6 on human thymic epithelial cells. J Exp Med 181:1563, 1995.
P.66 掲載の参考文献
6) Ware RE, Scearce RM, Dietz MA, Starmer CF, Palker TJ, Haynes BF:Characterization of the surface topography and putative tertiary structure of the human CD7 molecule. J Immunol 143 (11):3632-3640, 1989.
P.68 掲載の参考文献
5) Norment AM, Lonberg N, Lacy E, Littman DR:Alternatively spliced mRNA encodes a secreted form of human CD8 alpha. Characterization of the human CD8 alpha gene. J Immunol 142 (9):3312-3319, 1989.
6) Nakayama K, Kawachi Y, Tokito S, Minami N, Yamamoto R, Imai T, Gachelin G, Nakauchi H:Recent duplication of the two human CD8 beta-chain genes. J Immunol 148 (6):1919-1927, 1992.
8) Nakayama K, Kawachi Y, Tokito S, Minami N, Yamamoto R, Imai T, Gachelin G, Nakauchi H:Recent duplication of the two human CD8 beta-chain genes. J Immunol 148 (6):1919-1927, 1992.
P.70 掲載の参考文献
4) Boucheix C, Benoit P, Frachet P, Billard M, Worthington RE, Gagnon J, Uzan G:Molecular cloning of the CD9 antigen. A new family of cell surface proteins. J Biol Chem 266:117, 1991.
6) Iwamoto R, Higashiyama S, Mitamura T, Taniguchi N, Klagsbrun M, Mekada E:Heparin-binding EGF-like growth factor, which acts as the diphtheria toxin receptor, forms a complex with membrane protein DRAP27/CD9, which up-regulates functional receptors and diphtheria toxin sensitivity. EMBO J 13:2322, 1994.
8) Le Naour F, Prenant M, Francastel C, Rubinstein E, Uzan G, Boucheix C:Transcriptional regulation of the human CD9 gene:characterization of the 5'-flanking region. Oncogene 13:481, 1996
9) Loffler S, Lottspeich F, Lanza F, Azorsa DO, ter Meulen V, Schneider-Schaulies J:CD9, a tetraspan transmembrane protein, renders cells susceptible to canine distemper virus. J Virol 71:42, 1997.
10) Oritani K, Wu X, Medina K, Hudson J, Miyake K, Gimble JM, Burstein SA, Kincade PW:Antibody ligation of CD9 modifies production of myeloid cells in long-term cultures. Blood 87:2252, 1996.
15) Tai XG, Yashiro Y, Abe R, Toyooka K, Wood CR, Morris J, Long A, Ono S, Kobayashi M, Hamaoka T, Neben S, Fujiwara H:Arole for CD9 molecules in T cell activation. J Exp Med 184:753, 1996.
16) Willett BJ, Hosie MJ, Jarrett O, Neil JC:Identification of a putative cellular receptor for feline immunodeficiency virus as the feline homologue of CD9. Immunology 81:228, 1994.
P.72 掲載の参考文献
9) D'Adamio L, Shipp MA, Masteller EL, Reinherz EL:Organization of the gene encoding common acute lymphoblastic leukemia antigen (neutral endopeptidase 24.11):multiple miniexons and separate 5' untranslated regions. Proc Natl Acad Sci USA 86 (18):7103-7107, 1989.
11) Barker PE, Shipp MA, D'Adamio L, Masteller EL, Reinherz EL:The common acute lymphoblastic leukemia antigen gene maps to chromosomal region 3 (q21-q27). J Immunol 142 (1):283-287, 1989.
P.75 掲載の参考文献
4) Martz E:Leukocyte function-associated antigen one (LFA-1). Encyclopedia of Immunology, 2nd ed, (eds Ivan M Roitt, Peter J Delves), Academic Press, London, 1997.
7) Sanchez-Mateos P, Cabanas C, Sanchez-Madrid F:Regulation of integrin function. Semin Cancer Biol 7:99, 1996.
15) Schmits R, Kundig TM, Baker DM, Shumaker G, Simard JJ, Duncan G, Wakeham A, Shahinian A, van der Heiden A, Bachmann MF, Ohashi PS, Mak TW, Hickstein DD:LFA-1-deficient mice show normal CTL responses to virus but fail to relect immunogenic tumor. J Exp Med 183:1415, 1996.
P.78 掲載の参考文献
6) Corbi AL, Kishimoto TK, Miller LJ, Springer TA:The human leukocyte adhesion glycoprotein Mac-1 (complement receptor type 3, CD11b) alpha subunit. Cloning, primary structure, and relation to the integrins, von Willebrand factor and factor B. J Biol Chem 263:12403, 1988.
P.80 掲載の参考文献
1) Corbi AL:In 'Leukocyte Integrins:structure, expression and function'. Springer (Heidelberg, Ger-many)/RG. Landes (Gergetown, Texas) Ed, 1996.
5) Corbi AL, Miller LJ, O'Connor K, Larson RS, Springer TA:cDNA cloning and complete primary structure of the alpha subunit of a leukocyte adhesion glycoprotein, p150, 95. EMBO J 6:4023, 1987.
8) Lopez-Rodriguez C, Kluin-Nelemans HC, Corbi AL:AP-1 regulates the basal and developmentally induced transcription of the CD11c leukocyte integrin gene. J Immunol 156:3780, 1996.
10) Sanchez-Madrid F, Nagy JA, Robbins E, Simon P, Springer TA:A human leukocyte differentiation antigen family with distinct alpha-subunits and a common beta-subunit:the lymphocyte function-associated antigen (LFA-1), the C3bi complement receptor (OKM1/Mac-1), and the p150, 95 molecule. J Exp Med 158:1785,1983.
P.81 掲載の参考文献
1) Bernard A:In Leukocyte Typing, (eds Bernard A, et al), Springer-Verlag, Berlin, p82, 1984.
2) Knapp W:In Leukocyte Typing IV, (eds Knapp W, et al), Oxford University Press, p781, 1989.
3) Marinov J, Koubek K, Stary J:Expression of CDw12 and CD17 cell surface antigens on leukemic cells from patients with blood malignancies. Folia Biol (Praha) 39:124, 1993.
4) Pui CH, Behm FG, Singh B, Rivera GK, Schell MJ, Roberts WM, Crist WM, Mirro J Jr:Myeloid-associated antigen expression lacks prognostic value in childhood acute lymphoblastic leukemia treated with intensive multiagent chemotherapy. Blood 75:198, 1990.
5) Stain C, Stockinger H, Scharf M, Jager U, Gossinger H, Lechner K, Bettelheim P:Human blood basophils display a unique phenotype including activation linked membrane structures. Blood 70:1872, 1987.
6) van der Schoot CE, et al:In Leukocyte Typing IV, (eds Knapp W, et al), Oxford University Press, pp868-876, 1989.
P.82 掲載の参考文献
1) Ashmun RA, Holmes KV, Shapiro LH, et al:In Leukocyte Typing III (ed771-774)
6) Soderberg C, Giugni TD, Zaia JA, Larsson S, Wahlberg JM, Moller E:CD13 (human aminopeptidase N) mediates human cytomegalovirus infection. J Virol 67:6576-6585, 1993.
7) Soderberg C, Larsson S, Rozell BL, Sumitran-Karuppan S, Ljungman P, Moller E:Cytomegalovirus-induced CD13-specific autoimmunity-a possible cause of chronic graft-vs-host disease. Transplantation 61:600-609, 1996.
P.85 掲載の参考文献
1) Bazil V, Strominger JL:Shedding as a mechanism of down-modulation of CD14 on stimulated human monocytes. J Immunol 147:1567, 1991.
7) Goyert SM, Ferrero EM, Seremetis SV, Winchester RJ, Silver J, Mattison AC:Biochemistry and expression of myelomonocytic antigens. J Immunol 137:3909, 1986.
8) Hailman E, Lichenstein HS, Wurfel MM, Miller DS, Johnson DA, Kelley M, Busse LA, Zukowski MM, Wright SD:Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14. J Exp Med 179:269, 1994.
11) Haziot A, Tsuberi BZ, Goyert SM:Neutrophil CD14:biochemical properties and role in the secretion of tumor necrosis factor-alpha in response to lipopolysaccharide. J Immunol 150:5556, 1993.
12) Haziot A, Katz I, Jiao D, Rong G-W, Goyert SM:Functional epitopes of CD14. White cell differentiation antigens. In Leukocyte Typing V, (eds Schlossman SF, et al), Oxford University Press, pp782-784, 1995.
P.87 掲載の参考文献
1) Liu Y, Zhu X, Zhuang H, Lin H, Wu Q, Jiang G, Gu Y, Luo D, Luo X:Diagnosis and differential diagnosis of nodular lymphocyte-predominant Hodgkin's lymphoma. Zhonghua Bing Li Xue Za Zhi 31 (3):227-230, 2002.
5) Reyes-Botella C, Montes MJ, Vallecillo-Capilla MF, Olivares EG, Ruiz C:Antigenic phenotype of cultured human osteoblast-like cells. Cell Physiol Biochem 12 (5-6):359-364, 2002.
13) Mata-Greenwood E, Cuendet M, Sher D, Gustin D, Stock W, Pezzuto JM:Brusatol-mediated induction of leukemic cell differentiation and G (1) arrest is associated with down-regulation of c-myc. Leukemia 16 (11):2275-2284, 2002.
19) Heller DS, Haefner HK, Hameed M, Lieberman RW:Vulvar hidradenitis suppurativa. Immunohisto-chemical evaluation of apocrine and eccrine involvement. J Reprod Med 47 (9):695-700, 2002.
P.90 掲載の参考文献
6) Stammberger U, Hamacher J, Hillinger S, Schmid RA:sCR1sLe ameliorates ischemia/reperfusion injury in experimental lung transplantation. J Thorac Cardiovasc Surg 120 (6):1078-1084, 2000.
P.92 掲載の参考文献
P.94 掲載の参考文献
P.96 掲載の参考文献
1) Iwabuchi K, Nagaoka I:Cellular functions and signal transduction through glycosignaling domain:lactosylceramide mediated superoxide generation from neutrophils. Tanpakushitsu Kakusan Koso 47 (4 Suppl):357-364, 2002. (Japanese)
2) Inokuchi J, Kabayama K, Uemura S, Igarashi Y:Biological significance of lactosylceramide branching and domain formation:glycosphingolipids govern gene expression. Tanpakushitsu Kakusan Koso 47 (4 Suppl):371-378, 2002. (Japanese)
3) Hahn PY, Evans SE, Kottom TJ, Standing JE, Pagano RE, Limper AH:Pneumocystis carinii cell wall beta-glucan induces release of macrophage inflammatory protein-2 from alveolar epithelial cells via a lactosylceramide mediated mechanism. J Biol Chem 278 (3):2043-2050, 2003.
5) Iwabuchi K, Nagaoka I:Lactosylceramide-enriched glycosphingolipid signaling domain mediates super-oxide generation from human neutrophils. Blood 100 (4):1454-1464, 2002.
6) Plo I, Lehne G, Beckstrom KJ, Maestre N, Bettaieb A, Laurent G, Lautier D:Influence of ceramide metabolism on P-glycoprotein function in immature acute myeloid leukemia KGIa cells. Mol Pharmacol 62 (2):304-312, 2002.
18) Hulkova H, Cervenkova M, Ledvinova J, Tochackova M, Hrebicek M, Poupetova H, Befekadu A, Berna L, Paton BC, Harzer K, Boor A, Smid F, Elleder M:A novel mutation in the coding region of the prosaposin gene leads to a complete deficiency of prosaposin and saposins, and is associated with a complex sphingolipidosis dominated by lactosylceramide accumulation. Hum Mol Genet 10 (9):927-940, 2001.
21) Symington FW:CDw17:aneutrophil glycolipid antigen regulated by activation. J Immunol 142:2784, 1989.
P.99 掲載の参考文献
P.101 掲載の参考文献
7) Nadler LM, Anderson KC, Marti G, Bates M, Park E, Daley JF, Schlossman SF:B4, a human B lymphocyte-associated antigen expressed on normal, mitogen-activated, and malignant B lymphocytes. J Immunol 131:244, 1983.
8) Pezzutto A, Dorken B, Rabinovitch PS, Ledbetter JA, Moldenhauer G, Clark EA:CD19 monoclonal antibody HD37 inhibits anti-immunoglobulin-induced B cell activation and proliferation. J Immunol 138:2793, 1987.
11) Steeber DA, Green NE, Sato S, Tedder TF:Lyphocyte migration in L-selectin-deficient mice. Altered subset migration and aging of the immune system. J Immunol 157:1096, 1996.
12) Tedder TF, Isaacs CM:Isolation of cDNAs encoding the CD19 antigen of human and mouse B lymphocytes. A new member of the immunoglobulin superfamily. J Immunol 143:712, 1989.
14) Weng WK, Jarvis L, LeBien TW:Signaling through CD19 activates Vav/mitogen-activated protein kinase pathway and induces formation of a CD19/Vav/phosphatidylinositol 3-kinase complex in human B cell precursors. J Biol Chem 269:32514, 1994.
P.103 掲載の参考文献
P.105 掲載の参考文献
3) Carel JC, Myones BL, Frazier B, Holers VM:Structural requirements for C3d, g/Epstein-Barr virus receptor (CR2/CD21) ligand binding, internalization, and viral infection. J Biol Chem 265:12293, 1990.
4) Knowles DM 2d, Tolidjian B, Marboe CC, Mittler RS, Talle MA, Goldstein G:Distribution of antigens defined by OKB monoclonal antibodies on benign and malignant lymphoid cells and on nonlymphoid tissues. Blood 63:886, 1984.
6) Nadler LM, Stashenko P, Hardy R, van Agthoven A, Terhorst C, Schlossman SF:Characterization of a human B cell-specific antigen (B2) distinct from. J Immunol 126:1941, 1981.
P.107 掲載の参考文献
3) Dorken B, Moldenhauer G, Pezzutto A, Schwartz R, Feller A, Kiesel S, Nadler LM:HD39 (B3), a B lineage-restricted antigen whose cell surface expression is limited to resting and activated human B lymphocytes. J Immunol 136:4470, 1986.
4) Engel P, Nojima Y, Rothstein D, Zhou LJ, Wilson GL, Kehrl JH, Tedder TF:The same epitope on CD22 of B lymphocytes mediates the adhesion of erythrocytes, T and B lymphocytes, neutrophils, and monocytes. J Immunol 150:4719, 1993.
P.109 掲載の参考文献
P.111 掲載の参考文献
9) Jackson D, Waibel R, Weber E, Bell J, Stahel RA:CD24, a signal-transducing molecule expressed on human B cells, is a major surface antigen on small cell lung carcinomas. Cancer Res 52:5264, 1992.
P.114 掲載の参考文献
P.116 掲載の参考文献
1) Morimoto C, Schlossman SF:CD26, a key costimulatory molecule on CD4 memory T cells. Immunologist 2:4, 1994.
4) Stein H, Schwarting R, Niedobitek G:In Leucocyte typing IV, (eds Knapp W, et al), Oxford University Press, p412, 1989.
P.118 掲載の参考文献
P.120 掲載の参考文献
P.122 掲載の参考文献
P.125 掲載の参考文献
3) de Bruin PC, Gruss HJ, van der Valk P, Willemze R, Meijer CJ:CD30 expression in normal and neoplastic lymphoid tissue:biological aspects and clinical implications. Leukemia 9:1620, 1995.
15) Hamann D, Hilkens CM, Grogan JL, Lens SM, Kapsenberg ML, Yazdanbakhsh M, van Lier RA:CD30 expression does not discriminate between human Th1-and Th2-type T cells. J Immunol 156:1387, 1996.
P.127 掲載の参考文献
6) DeLisser HM, Christofidou-Solomidou M, Strieter RM, .Burdick MD, Robinson CS, Wexler RS, Kerr JS, Garlanda C, Merwin JR, Madri JA, Albelda SM:Involvement of endothelial PECAM-1/CD31 in angiogenesis. Am J Pathol 151:671, 1997.
P.129 掲載の参考文献
P.131 掲載の参考文献
6) Peiper SC, Andrews RG:CD33 cluster workshop report. In Leukocyte Typing V, (eds Schlossman SF, Boumsell L, Gilks W, Harlan JM, Kishimoto T, Morimoto C, Ritz J, Shaw S, Silverstein R, Springer T, Tedder TF, Todd RF) , Oxford University Press, pp837-840, 1995.
9) Simmons D, Seed B:Isolation of a cDNA encoding CD33, a differentiation antigen of myeloid progenitor cells. J Immunol 141:2797-2800, 1988.
P.134 掲載の参考文献
6) Gaudernack G, Egeland, T:In Leucocyte Typing V, (eds Schlossman SF, et al) , Oxford University Press, pp861-864.1995.
9) Nakamura Y, Komano H, Nakauchi H:Two alternative forms of cDNA encoding CD34. Exp Hematol 21:236, 1993.
P.136 掲載の参考文献
2) Hourcade D, Holers VM, Atkinson JP:The regulators of complement activation (RCA) gene cluster. Adv Immunol 45:381, 1989.
P.138 掲載の参考文献
P.140 掲載の参考文献
P.142 掲載の参考文献
P.144 掲載の参考文献
P.146 掲載の参考文献
P.148 掲載の参考文献
P.150 掲載の参考文献
2) Fox JE, Aggerbeck LP, Berndt MC:Structure of the glycoprotein Ib. IX complex from platelet membranes. J Biol Chem 263:4882, 1988.
P.151 掲載の参考文献
P.153 掲載の参考文献
2) Fox JE, Aggerbeck LP, Berndt MC:Structure of the glycoprotein Ib. IX complex from platelet membranes. J Biol Chem 263:4882, 1988.
P.154 掲載の参考文献
P.156 掲載の参考文献
P.158 掲載の参考文献
1) Haynes BF, Liao HX, Patton KL:The transmembrane hyaluronate receptor (CD44):multiple functions, multiple forms. Cancer Cells 3:347, 1991.
3) Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B:CD44 is the principal cell surface receptor for hyaluronate. Cell 61:1303, 1990.
P.160 掲載の参考文献
1) Haynes BF, Liao HX, Patton KL:The transmembrane hyaluronate receptor (CD44):multiple functions, multiple forms. Cancer Cells 3:347, 1991.
P.162 掲載の参考文献
3) Beverley PCL:In Production and Use of Monoclonal Antibodies in Transplantation Immunology. In Transplantation and Clinical Immunology XI, (eds Touraine JL, et al), Excerpta Medica, Amsterdam, pp87-94, 1980.
11) Terry LA, Brown MH, Beverley PC:The monoclonal antibody, UCHL1, recognizes a 180,000 MW component of the human leucocyte-common antigen, CD45. Immunology 64:331, 1988.
P.164 掲載の参考文献
・Cobbold S, Hale G, Waldmann H:In Leukocyte Typing III, (eds McMichael AJ, et al), Oxford University Press, p789, 1987.
P.165 掲載の参考文献
P.167 掲載の参考文献
P.168 掲載の参考文献
10) Kitamura M, Namiki M, Matsumiya K, Tanaka K, Matsumoto M, Hara T, Kiyohara H, Okabe M, Okuyama A, Seya T:Membrane cofactor protein (CD46) in seminal plasma is a prostasome-bound form with complement regulatory activity and measles virus neutralizing activity. Immunology 84:626, 1995.
15) Niehans GA, Cherwitz DL, Staley NA, Knapp DJ, Dalmasso AP:Human carcinomas variably express the complement inhibitory proteins CD46 (membrane cofactor protein), CD55 (decay-accelerating factor), and CD59 (protectin). Am J Pathol 149:129, 1996.
20) Purcell DF, McKenzie IF, Lublin DM, Johnson PM, Atkinson Jp, Oglesby TJ, Deacon NJ:The human cell-surface glycoproteins HuLy-m5, membrane co-factor protein (MCP) of the complement system, and trophoblast leucocyte-common (TLX) antigen, are CD46. Immunology 70:155, 1990.
P.171 掲載の参考文献
1) Anstee DJ, Spring FA:In Leucocyte Typing V, (eds Schlossman SF, et al), Oxford University Press, pp233-234, 1995.
3) Campbell IG, Freemont PS, Foulkes W, Trowsdale J:An ovarian tumor marker with homology to vaccinia virus contains an IgV-like region and multiple transmembrane domains. Cancer Res 52:5416, 1992.
P.172 掲載の参考文献
1) Arvieux J, Jefferies WA, Paterson DJ, Williams AF, Green JR:Monoclonal antibodies against a rat leucocyte antigen block antigen-induced T-cell responses via an effect on accessory cells. Immunology 58:337, 1986.
P.174 掲載の参考文献
P.176 掲載の参考文献
P.178 掲載の参考文献
P.179 掲載の参考文献
P.182 掲載の参考文献
11) El Mourabit H, Poinat P, Koster J, Sondermann H, Wixler V, Wegener E, Laplantine E, Geerts D, Georges-Labouesse E, Sonnenberg A, Aumailley M:The PDZ domain of TIP-2/GIPC interacts with the C-terminus of the integrin alpha 5 and alpha 6 subunits. Matrix Biol 21 (2):207-214, 2002.
P.184 掲載の参考文献
2) Davis TL, Buerger F, Cress AE:Differential regulation of a novel variant of the alpha (6) integrin, alpha (6p). Cell Growth Differ 13 (3):107-113, 2002.
3) El Mourabit H, Poinat P, Koster J, Sondermann H, Wixler V, Wegener E, Laplantine E, Geerts D, Georges-Labouesse E, Sonnenberg A, Aumailley M:The PDZ domain of TIP-2/GIPC interacts with the C-terminus of the integrin alpha 5 and alpha 6 subunits. Matrix Biol 21 (2):207-214, 2002.
11) Starr L, Quaranta V:An efficient and reliable method for cloning PCR-amplification products:a survey of point mutations in integrin cDNA. Biotechniques 13 (4):612-618, 1992.
P.186 掲載の参考文献
1) Acevedo A, del Pozo MA, Arroyo AG, Sanchez-Mateos P, Gonzalez-Amaro R, Sanchez-Madrid F:Distribution of ICAM-3-bearing cells in normal human tissues. Expression of a novel counter-receptor for LFA-1 in epidermal Langerhans cells. Am J Pathol 143:774-783, 1993.
P.188 掲載の参考文献
P.190 掲載の参考文献
P.192 掲載の参考文献
P.194 掲載の参考文献
P.196 掲載の参考文献
4) Nicholson-Weller A, Wang CE:Structure and function of decay accelerating factor CD55. J Lab Clin Med 123:485, 1994.
14) Niehans GA, Cherwitz DL, Staley NA, Knapp DJ, Dalmasso AP:Human carcinomas variably express the complement inhibitory proteins CD46 (membrane cofactor protein), CD55 (decay-accelerating factor), and CD59 (protectin). Am J Pathol 149:129, 1996.
P.198 掲載の参考文献
6) Barton CH, Dickson G, Gower HJ, Rowett LH, Putt W, Elsom V, Moore SE, Goridis C, Walsh FS:Complete sequence and in vitro expression of a tissue-specific phosphatidylinositol-linked N-CAM isoform from skeletal muscle. Development 104:165, 1988.
P.200 掲載の参考文献
P.201 掲載の参考文献
P.203 掲載の参考文献
4) Venneker GT, Asghar SS:CD59:a molecule involved in antigen presentation as well as downregulation of membrane attack complex. Exp Clin Immunogenet 9:33, 1992
13) Meri S, Waldmann H, Lachmann PJ:Distribution of protectin (CD59), acomplement membrane attack inhibitor, in normal human tissues. Lab Invest 65:532, 1991.
P.205 掲載の参考文献
P.206 掲載の参考文献
P.207 掲載の参考文献
P.209 掲載の参考文献
P.212 掲載の参考文献
7) Koch AE, Burrows JC, Haines GK, Carlos TM, Harlan JM, Leibovich SJ:Immunolocalization of endothelial and leukocyte adhesion molecules in human rheumatoid and osteoarthritic synovial tissues. Lab Invest 64:313, 1991.
P.214 掲載の参考文献
4) Spertini O, Freedman AS, Belvin MP, Penta AC, Griffin JD, Tedder TF:Regulation of leukocyte adhesion molecule-1 (TQ1, Leu-8) expression and shedding by normal and malignant cells. Leukemia 5:300, 1991.
P.216 掲載の参考文献
P.218 掲載の参考文献
14) Vischer UM, Wagner DD:CD63 is a component of Weibel-Palade bodies of human endothelial cells. Blood 82:1184, 1993.
P.220 掲載の参考文献
2) Van de Winkel JGJ, Capel PJA (eds):Human IgG Fc Receptors. RG Landes Company, Austin, TX, USA, 1996.
P.222 掲載の参考文献
5) Ludwig WD, Rieder H, Bartram CR, Heinze B, Schwartz S, Gassmann W, Loffler H, Hossfeld D, Heil G, Handt S, Heyll A, Diedrich H, Fischer K, Weiss A, Volkers B, Aydemir U, Fonatsch C, Gokbuget N, Thiel E, Hoelzer D:Immunophenotypic and genotypic features, clinical characteristics, and treatment outcome of adult pro-B acute lymphoblastic leukemia:results of the German multicenter trials GMALL 03/87 and 04/89. Blood 92 (6):1898-1909, 1998.
6) Dreyling MH, Schrader K, Fonatsch C, Schlegelberger B, Haase D, Schoch C, Ludwig W, Loffler H, Buchner T, Wormann B, Hiddemann W, Bohlander SK:MLL and CALM are fused to AF10 in morphologically distinct subsets of acute leukemia with translocation t (10;11):both rearrangements are associated with a poor prognosis. Blood 91 (12):4662-4667, 1998.
P.225 掲載の参考文献
2) Svenberg T, Hammarstrom S, Zeromski J:Immunofluorescence studies on the occurrence and localization of the CEA-related biliary glycoprotein I (BGP I) in normal human gastrointestinal tissues. Clin Exp Immunol 36:436, 1979.
6) Rojas M, Fuks A, Stanners CP:Biliary glycoprotein, a member of the immunoglobulin supergene family, functions in vitro as a Ca2 (+)-dependent intercellular adhesion molecule. Cell Growth Differ 1:527, 1990.
10) Skubitz KM, Campbell KD, Ahmed K, Skubitz AP:CD66 family members are associated with tyrosine kinase activity in human neutrophils. J Immunol 155:5382, 1995.
P.226 掲載の参考文献
3) Berling B, Kolbinger F, Grunert F, Thompson JA, Brombacher F, Buchegger F, von Kleist S, Zimmermann W:Cloning of a carcinoembryonic antigen gene family member expressed in leukocytes of chronic myeloid leukemia patients and bone marrow. Cancer Res 50:6534, 1990.
7) Skubitz KM, Campbell KD, Ahmed K, Skubitz AP:CD66 family members are associated with tyrosine kinase activity in human neutrophils. J Immunol 155:5382, 1995.
P.228 掲載の参考文献
8) Skubitz KM, Campbell KD, Ahmed K, Skubitz AP:CD66 family members are associated with tyrosine kinase activity in human neutrophils. J Immunol 155:5382, 1995.
9) Ohannesian DW, Lotan D, Thomas P, Jessup JM, Fukuda M, Gabius HJ, Lotan R:Carcinoembryonic antigen and other glycoconjugates act as ligands for galectin-3 in human colon carcinoma cells. Cancer Res 55:2191, 1995.
P.229 掲載の参考文献
P.230 掲載の参考文献
8) Chen CJ, Li LJ, Maruya A, Shively JE:In vitro and in vivo footprint analysis of the promoter ofcarcinoembryonic antigen in colon carcinoma cells:effects of interferon gamma treatment. Cancer Res 55:3873, 1995.
9) Gangopadhyay A, Bajenova O, Kelly TM, Thomas P:Carcinoembryonic antigen induces cytokine expression in Kuppfer cells:implications for hepatic metastasis from colorectal cancer. Cancer Res 56:4805, 1996.
P.231 掲載の参考文献
P.233 掲載の参考文献
1) Cordell JL, Falini B, Flenghi L, Jones DB, Pileri S, Radzun HJ, Wilkins BS:In Leukocyte Typing V, (eds Schlossman SF, et al) , Oxford University Press, pp925-927, 1995.
3) Fukuda M:Lysosomal membrane glycoproteins. Structure, biosynthesis, and intracellular trafficking. J Biol Chem 266:21327, 1991.
10) Stockinger H:In Leukocyte Typing IV, (eds Knapp W, et al), Oxford University Press, pp841-843, 1989.
P.235 掲載の参考文献
1) Sanchez-Madrid F:In Leukocyte Typing V, (eds Schlossman, et al), Oxford University Press, pp1123-1124, 1995.
P.237 掲載の参考文献
3) Wischhusen J, Jung G, Radovanovic I, Beier C, Steinbach Jp, Rimner A, Huang H, Schulz JB, Ohgaki H, Aguzzi A, Rammensee HG, Weller M:Identification of CD70-mediated apoptosis of immune effector cells as a novel immune escape pathway of human glioblastoma. Cancer Res 62 (9):2592-2599, 2002.
P.238 掲載の参考文献
3) Barclay AN, Birkeland ML, Brown MH, Beyers BD, Davis SJ, Somoza C, Williams AF:In The Leucocyte Antigen Facts Book, (eds Barclay AN, et al), Academic Press, London, pp258-259, 1993.
6) Israeli RS, Powell CT, Fair WR, Heston WD:Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen. Cancer Res 53:227, 1993.
P.240 掲載の参考文献
P.242 掲載の参考文献
11) Airas L, Jalkanen S:CD73 mediates adhesion of B cells to follicular dendritic cells. Blood 88:1755, 1996.
P.244 掲載の参考文献
P.246 掲載の参考文献
P.247 掲載の参考文献
P.249 掲載の参考文献
3) Gregory CD, Tursz T, Edwards CF, Tetaud C, Talbot M, Caillou B, Rickinson AB, Lipinski M:Identification of a subset of normal B cells with a Burkitt's lymphoma. J Immunol 139:313, 1987.
P.250 掲載の参考文献
2) Kikutani H, Kimura R, Nakamura H, et al:Expression and function of an early activation marker restricted to human B cells. J Immunol 136:4019, 1986.
3) Kikutani H, Nakamura H, Sato R, et al:Delineation and characterization of human B cell subpopulations at various stages of activation by using a B cell-specific monoclonal antibody. J Immunol 136:4027, 1986.
4) Dorken B, Moller P, Pezzutto A, et al:B-cell antigens:CDw78. In Leukocyte Typing IV, (eds Knapp W, et al), Oxford University Press, pp122-123, 1989.
5) Bradbury LE, Kansas GS, Levy S, Evans RL, Tedder TF:The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules. J Immunol 149:2841-2850, 1992.
P.252 掲載の参考文献
5) Ha H, Barnoski BL, Sun L, Emanuel BS, Burrows PD:Structure, chromosomal localization, and methylation pattern of the human mb-1 gene. J Immunol 152 (12):5749-5757, 1994.
9) Yu LM, Chang TW:Human mb-1 gene:complete cDNA sequence and its expression in B cells bearing membrane Ig of various isotypes. J Immunol 148 (2):633-637, 1992.
11) Ha HJ, Kubagawa H, Burrows PD:Molecular cloning and expression pattern of a human gene homologous to the murine mb-1 gene. J Immunol 148 (5):1526-1531, 1992.
P.254 掲載の参考文献
8) Hashimoto S, Gregersen PK, Chiorazzi N:The human lg-beta cDNA sequence, a homologue of murine B29, is identical in B cell and plasma cell lines producing all the human Ig isotypes. J Immunol 150 (2):491-498, 1993,
P.256 掲載の参考文献
1) Engel P, Wagner N, Tedder TF:In Leucocyte Typing V, (eds Schlossman SF, et al), Oxford University Press, pp 682-684, 1995.
2) Freedman AS, Freeman G, Horowitz JC, Daley J, Nadler LM:B7, a B-cell-restricted antigen that identifies preactivated B cells. J Immunol 139:3260, 1987.
4) Freeman GJ, Freedman AS, Segil JM, Lee G, Whitman JF, Nadler LM:B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells. J Immunol 143:2714, 1989.
9) Yokochi T, Holly RD, Clark EA:Blymphoblast antigen (BB-1) expressed on Epstein-Barr virus-activated B cell blasts, B lymphoblastoid cell lines, and Burkitt's lymphomas. J Immunol 128:823, 1982.
P.257 掲載の参考文献
2) Andria ML, Hsieh CL, Oren R, Francke U, Levy S:Genomic organization and chromosomal localization of the TAPA-1 gene. J Immunol 147:1030, 1991.
3) Bradbury LE, Goldmacher VS, Tedder TF:The CD19 signal transduction complex of B lymphocytes. Deletion of the CD19 cytoplasmic domain alters signal transduction but not complex formation with TAPA-1 and Leu 13. J Immunol 151:2915, 1993.
4) Bradbury LE, Kansas GS, Levy S, Evans RL, Tedder TF:The CD19/CD21 signal transducing complex f human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules. J Immunol 149:2841, 1992.
5) Bradbury L, Tedder TF:In Leucocyte Typing V, eds Schlossman SF, et al) , Oxford University Press, pp690-691, 1995.
6) Freedman A, Phifer JS, Svahn J:In Leucocyte Typing V, (eds Schlossman SF, et al) , Oxford University Press, pp732-733, 1995.
8) Schick MR, Nguyen VQ, Levy S:Anti-TAPA-1 antibodies induce protein tyrosine phosphorylation that is prevented by increasing intracellular thiol levels. J Immunol 151:1918, 1993.
9) Takahashi S, Doss C, Levy S, Levy R:TAPA-1, the target of an antiproliferative antibody, is associated on the cell surface with the Leu-13 antigen. J Immunol 145:2207, 1990.
10) Tedder TF, Wagner N, Engel P:In Leucocyte Typing V, (eds Schlossman SF, et al) , Oxford University Press, 1995.
11) Vaickus L, Levy R:Antiproliferative monoclonal antibodies:detection and initial characterization. J Immunol 135:1987, 1985.
P.259 掲載の参考文献
4) Gil ML, Vita N, Lebel-Binay S, Miloux B, Chalon P, Kaghad M, Marchiol-Fournigault C, Conjeaud H, Caput D, Ferrara P, et al:Amember of the tetra spans transmembrane protein superfamily is recognized by a monoclonal antibody raised against an HLA class I-deficient, lymphokine-activated killer susceptible, B lymphocyte line. Cloning and preliminary functional studies. J Immunol 148:2826, 1992.
6) Imai T, Fukudome K, Takagi S, Nagira M, Furuse M, Fukuhara N, Nishimura M, Hinuma Y, Yoshie O:C33 antigen recognized by monoclonal antibodies inhibitory to human T cell leukemia virus type 1-induced syncytium formation is a member of a new family of transmembrane proteins including CD9, CD37, CD53, and CD63. J Immunol 149:2879, 1992.
7) Imai T, Yoshie O:C33 antigen and M38 antigen recognized by monoclonal antibodies inhibitory to syncytium formation by human T cell leukemia virus type 1 are both members of the transmembrane 4 superfamily and associate with each other and with CD40r CD8 in T cells. J Immunol 151:6470, 1993.
11) Imai T, Kakizaki M, Nishimura M, Yoshie O:Molecular analyses of the association of CD4 with two members of the transmembrane 4 superfamily, CD81 and CD82. J Immunol 155:1229, 1995.
13) Lebel-Binay S, Lagaudriere C, Fradelizi D, Conjeaud H:CD82, member of the tetra-span-transmembrane protein family, is a costimulatory protein for T cell activation.J Immunol 155:101, 1995.
16) Lagaudriere-Gesbert C, Lebel-Binay S, Wiertz E, Ploegh HL, Fradelizi D, Conjeaud H:The tetraspanin protein CD82 associates with both free HLA class I heavy chain and heterodimeric beta 2-microglobulin complexes. J Immunol 158:2790, 1997.
17) Szollosi J, Horejsi V, Bene L, Angelisova P, Damjanovich S:Supramolecular complexes of MHC class I, MHC class II, CD20, and tetraspan molecules (CD53, CD81, and CD82) at the surface of a B cell line JY. J Immunol 157:2939, 1996.
P.260 掲載の参考文献
1) Egner W, Hart DN:The phenotype of freshly isolated and cultured human bone marrow allostimulatory cells:possible heterogeneity in bone marrow dendritic cell populations. Immunology 85:611, 1995.
2) Engel P, Wagner N, Tedder TF:White Cell Differentiation Antigens. In Leukocyte Typing V, (eds Schlossman SF) , Oxford University Press, p693, 1995.
6) Zhou LJ, Schwarting R, Smith HM, Tedder TF:Anovel cell-surface molecule expressed by human interdigitating reticulum cells, Langerhans cells, and activated lymphocytes is a new member of the Ig superfamily. J Immunol 149:735, 1992.
7) Zhou LJ, Tedder TF:A distinct pattern of cytokine gene expression by human CD83+blood dendritic cells. Blood 86:3295, 1995.
9) Zhou LJ, Tedder TF:Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily. J Immunol 154:3821, 1995.
P.262 掲載の参考文献
1) Engel P, Smith H, Tedder TF:Phenotypic analysis with the B-cell unknown panel mAb. In Leukocyte Typing V, (eds Schlossman SF, et al), Oxford University Press, pp 607-620, 1995.
2) Engel P, Wagner N, Tedder TF:CDw84 workshop report. In Leukocyte Typing V, (eds Schlossman SF, et al), Oxford University Press, pp 699-700, 1995
P.264 掲載の参考文献
1) Engel P, Wagner R, Tedder TF:In Leucocyte typing V, (eds Schlossman SF, et al), Oxford University Press, pp 701-702, 1995.
3) Moldenhauer G, Schwarz-Albeiz R, Moller P:In Leucocyte typing V, (eds Schlossman SF, et al), Oxford University Press, pp 623-636, 1995.
5) Pulford K, Micklem KJ, Thomas J, Jones M, Law SK, Willis AC. et al:In Leucocyte typing V, (eds Schlossman SF, et al) , Oxford University Press, pp 702-703, 1995.
6) Wagner N, Engel P, Tedder TF:In Leucocyte typing V, (eds Schlossman SF, et al) , Oxford University Press, pp 636-642, 1995.
P.268 掲載の参考文献
4) Townsend SE, Su FW, Atherton JM, Allison JP:Specificity and longevity of antitumor immune responses induced by B 7-transfected tumors. Cancer Res 54:6477, 1994.
P.270 掲載の参考文献
6) Luther T, Magdolen V, Albrecht S, Kasper M, Riemer C, Kessler H, Graeff H, Muller M, Schmitt M:Epitope-mapped monoclonal antibodies as tools for functional and morphological analyses of the human urokinase receptor in tumor tissue. Am J Pathol 150:1231, 1997.
7) Mizukami IF, Vinjamuri SD, Trochelman RD, Todd RF 3rd:Astructural characterization of the Mo3 activation antigen expressed on the plasma membrane of human mononuclear phagocytes. J Immunol 144:1841, 1990.
9) Wei Y, Waltz DA, Rao N, Drummond RJ, Rosenberg S, Chapman HA:Identification of the urokinase receptor as an adhesion receptor for vitronectin. J Biol Chem 269:32380, 1994.
P.272 掲載の参考文献
P.274 掲載の参考文献
3) Morton HC, van Egmond M, van de Winkel JG:Structure and function of human IgA Fc receptors (Fc alpha R). Crit Rev Immunol 16:423, 1996.
4) Shen L, Lasser R, Fanger MW:My 43, a monoclonal antibody that reacts with human myeloid cells inhibits monocyte IgA binding and triggers function. J Immunol 143:4117, 1989.
7) Monteiro RC, Cooper MD, Kubagawa H:Molecular heterogeneity of Fc alpha receptors detected byreceptor-specific monoclonal antibodies. J Immunol 148:1764, 1992.
8) Pfefferkorn LC, Yeaman GR:Association of IgA-Fc receptors (Fc alpha R) with Fc epsilon RI gamma 2 subunits in U937 cells. Aggregation induces the tyrosine phosphorylation of gamma 2. J Immunol 153:3228, 1994.
10) Patry C, Sibille Y, Lehuen A, Monteiro RC:Identification of Fc alpha receptor (CD89) isoforms generated by alternative splicing that are differentially expressed between blood monocytes and alveolar macrophages. J Immunol 156:4442, 1996.
P.276 掲載の参考文献
P.277 掲載の参考文献
P.279 掲載の参考文献
1) Majdic O, Mai I, Pickl W F, Stockinger H, Knapp W:CDw92 (group 9) cluster workshop report. In Leukocyte Typing V. White cell differentiation antigens, Vol 1, (eds Schlossman SF, et al), Oxford University Press, pp 984-985, 1995.
1) Mai I, Pickl WF, Stockl J, Majdic O, Mellors A, De Smet W, et al:CD93 (group II) cluster workshop report. In Leukocyte Typing V. White cell differentiation antigens, Vol 1, (eds Schlossman SF, et al), Oxford University Press, pp 986-988, 1995.
2) Todd R:Myeloid antigens:section report. In Leukocyte Typing V. Whitecell differentiation antigens, Vol 1, (eds Schlossman SF, et al), Oxford University Press, pp769-770, 1995.
2) Todd R:Myeloid Antigens:Section report. In Leukocyte Typing V, Whitecell differentiation antigens, Vol 1, (eds Schlossman SF, et al), Oxford University Press, p769, 1995.
P.280 掲載の参考文献
3) Aramburu J, Balboa MA, Izquierdo M, Lopez-Botet M:Anovel functional cell surface dimer (Kp43) expressed by natural killer cells and gamma/delta TCR+T lymphocytes. II. Modulation of natural killer cytotoxicity by anti-Kp43 monoclonal antibody. J Immunol 147:714, 1991.
4) Brumbaugh KM, Perez-Villar JJ, Dick CJ, Schoon RA, Lopez-Botet M, Leibson PJ:Clonotypic differences in signaling from CD94 (kp43) on NK cells lead to divergent cellular responses. J Immunol 157:2804, 1996.
7) Lazetic S, Chang C, Houchins JP, Lanier LL, Phillips JH:Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits. J Immunol 157:4741, 1996.
8) Lopez-Botet M:In Leucocyte Typing V, (eds Schlossman SF, et al) , Oxford University Press, pp1437-1439, 1995.
10) Perez-Villar JJ, Carretero M, Navarro F, Melero I, Rodriguez A, Bottino C, Moretta A, Lopez-Botet M:Biochemical and serologic evidence for the existence of functionally distinct forms of the CD94 NK cell receptor. J Immunol 157:5367, 1996.
11) Perez-Villar JJ, Melero I, Rodriguez A, Carretero M, Aramburu J, Sivori S, Orengo AM, Moretta A, Lopez-Botet M:Functional ambivalence of the Kp43 (CD94) NK cell-associated surface antigen. J Immunol 154:5779, 1995.
P.283 掲載の参考文献
3) Nishimura Y, Ishii A, Yonehara S:Expression and function of apoptosis antigen Fas on T lymphocytes in periphery and thymus. In Leukocyte Typing V, (eds Schlossman SF, Boumsell L, Gilks W, Harlan JM, Kishimoto T, Morimoto C, Ritz J, Shaw S, Silverstein R, Springer T, Tedder TF, Todd RF), Oxford University Press, p1144, 1995.
P.284 掲載の参考文献
1) Wang PL, O'Farrell S, Clayberger C, Krensky AM:Identification and molecular cloning of tactile. A novel human T cell activation antigen that is a member of the Ig gene superfamily. J Immunol 148 (8):2600-2608, 1992.
P.285 掲載の参考文献
1) Pickl WF, Majdic O, Mai I, Gadd S, Knapp W:Overview of CD97. In Leukocyte Typing V, (eds Schlossman SF, Boumsell L, Gilks W, Harlan JM, Kishimoto T, Morimoto C, Ritz J, Shaw S, Silverstein R, Springer T, Tedder TF, Todd RF), Oxford University Press, pp1151-1153, 1995.
2) Hamann J, Eichler W, Vogel B, Stortelers C, Hamann D, Horejsi V, van Lier RA:CD97 workshop panel report. In Leukocyte Typing VI, (eds Kishimoto T, Kikutani H, von dem Borne AE, Goyert SM, Mason DY, Miyasaka M, Moretta L, Okumura K, Shaw S, Springer TA, Sugamura K, Zola H) , Garland Publishing Inc, New York, p527, 1998.
3) Aust G, Eichler W, Laue S, Lehmann I, Heldin NE, Lotz O, Scherbaum WA, Dralle H, Hoang-Vu C:CD97:adedifferentiation marker in human thyroid carcinomas. Cancer Res 57:1798-1806, 1997.
6) Gray JX, Haino M, Roth MJ, Maguire JE, Jensen PN, Yarme A, Stetler-Stevenson MA, Siebenlist U, Kelly K:CD97 is a processed, seven-transmembrane, heterodimeric receptor associated with inflammation. J Immunol 157:5438-5447, 1996.
7) Hamann J, Eichler W, Hamann D, Kerstens HM, Poddighe PJ, Hoovers JM, Hartmann E, Strauss M, van Lier RA:Expression cloning and chromosomal mapping of the leukocyte activation antigen CD97, a new seven-span transmembrane molecule of the secretion receptor superfamily with an unusual extracellular domain. J Immunol 155:1942-1950, 1995.
P.287 掲載の参考文献
1) Haynes BF, Hemler ME, Mann DL, Eisenbarth GS, Shdlhamer J, Mostowski HS, Thomas CA, Strominger JL, Fauci AS:Characterization of a monoclonal antibody (4F2) that binds to human monocytes and to a subset of activated lymphocytes. J Immunol 126:1409, 1981.
2) Ohgimoto S, Tabata N, Suga S, Nishio M, Ohta H, Tsurudome M, Komada H, Kawano M, Watanabe N, Ito Y:Molecular characterization of fusion regulatory protein-1 (FRP-1) that induces multinucleated giant cell formation of monocytes and HIV gp 160-mediated cell fusion. FRP-1 and 4F2/CD98 are identical molecules. J Immunol 155:3585, 1995.
8) Boumsell L:In Leucocyte Typing V, White cell differentiation antigens, eds Schlossman SF, et al), Oxford University Press, p280, 1995.
9) Wells RG, Lee WS, Kanai Y, Leiden JM, Hediger MA:The 4F2 antigen heavy chain induces uptake of neutral and dibasic amino acids in Xenopus oocytes. J Biol Chem 267:15285, 1992.
10) Palacin M:Anew family of proteins (rBAT and 4F2hc) involved in cationic and zwitterionic amino acid transport:atale of two proteins in search of a transport function. J Exp Biol 196:123, 1994.
11) Bron C, Rousseaux M, Spiazzi AL, MacDonald HR:Structural homology between the human 4F2 antigen and a murine cell surface glycoprotein associated with lymphocyte activation. J Immunol 137:397, 1986.
P.289 掲載の参考文献
4) Thomas De Montpreville V, Zemoura L, Dulmet E:Thymoma with epithelial micronodules and lymphoid hyperplasia:six cases of a rare and equivocal subtype. Ann Pathol 22 (3):177-182, 2002. (French)
10) Zamecnik M:Calcifying sclerosing tumor of the ovary:alate stage of sclerosing stromal tumor? Cesk Patol 38 (3):121-124, 2002.
11) Husek K, Vesely K:Extraorbital giant cell angiofibroma. Cesk Patol 38 (3):117-120, 2002.
13) Shidham VB, Chivukula M, Gupta D, Rao RN, Komorowski R:Immunohistochemical comparison of gastrointestinal stromal tumor and solitary fibrous tumor. A rch Pathol Lab Med 126 (10):1189-1192, 2002.
P.291 掲載の参考文献
P.292 掲載の参考文献
1) Bougeret C, Mansur IG, Dastot H, Schmid M, Mahouy G, Bensussan A, Boumsell L:Increased surface expression of a newly identified 150-kDa dimer early after human T lymphocyte activation. J Immunol 148:318, 1992.
3) Herold C, Dastot H, Bensussan A, Boumsell L:In Leucocyte Typing V, (eds Schlossman SF, Boumsell L, Gilks W, Harlan JM, Kishimoto T, Morimoto C, Ritz J, Shaw S, Silverstein R, Springer T, Tedder TF, Todd RF), Oxford University Press, pp 288-289, 1995.
4) Herold C, Dastot H, Bismuth G, Bensussan A, Boumsell L:In Leucocyte Typing V, (eds Schlossman SF, Boumsell L, Gilks W, Harlan JM, Kishimoto T, Morimoto C, Ritz J, Shaw S, Silverstein R, Springer T, Tedder TF, Todd RF), Oxford University Press, pp290-292, 1995.
5) Herold C, Elhabazi A, Bismuth G, Bensussan A, Boumsell L:CD100 is associated with CD45 at the surface of human T lymphocytes. Role in T cell homotypic adhesion. J Immunol 157 (12):5262-5268, 1996.
P.293 掲載の参考文献
1) Gouttefangeas C, Schmid M, Boumsell L, Bensussan A:In Leukocyte Typing V, Vol 1, (eds Schlossman SF, et al), Oxford University Press, pp293-295, 1995.
3) Ruegg CL, Rivas A, Madani ND, Zeitung J, Laus R, Engleman EG:V7, a novel leukocyte surface protein that participates in T cell activation. H. Molecular cloning and characterization of the V7 gene. J Immunol 154:4434, 1995.
4) Russell GJ, Parker CM, Sood A, Mizoguchi E, Ebert EC, Bhan AK, Brenner MB:p126 (CDw101), a costimulatory molecule preferentially expressed on mucosal T lymphocytes. J Immunol 157:3366, 1996.
P.294 掲載の参考文献
4) Li R, Nortamo P, Kantor C, Kovanen P, Timonen T, Gahmberg CG:Aleukocyte integrin binding peptide from intercellular adhesion molecule-2 stimulates T cell adhesion and natural killer cell activity. J Biol Chem 268:21474, 1993.
5) Li R, Nortamo P, Valmu L, Tolvanen M, Huuskonen J, Kantor C, Gahmberg CG:A peptide from ICAM-2 binds to the leukocyte integrin CD11a/CD18 and inhibits endothelial cell adhesion. J Biol Chem 268:17513, 1993.
8) Nortamo P, Salcedo R, Timonen T, Patarroyo M, Gahmberg CG:A monoclonal antibody to the human leukocyte adhesion molecule intercellular adhesion molecule-2. Cellular distribution and molecular characterization of the antigen. J Immunol 146:2530, 1991.
9) Renkonen R, Paavonen T, Nortamo P, Gahmberg CG:Expression of endothelial adhesion molecules in vivo. Increased endothelial ICAM-2 expression in lymphoid malignancies. Am J Pathol 140:763, 1992.
12) Xie J, Li R, Kotovuori P, Vermot-Desroches C, Wijdenes J, Arnaout MA, Nortamo P, Gahmberg CG:InterceUular adhesion molecule-2 (CD102) binds to the leukocyte integrin CD11b/CD18 through the A domain. J Immunol 155:3619, 1995.
P.296 掲載の参考文献
3) Cepek KL, Parker CM, Madara JL, Brenner MB:Integrin alpha E beta 7 mediates adhesion of T lymphocytes to epithelial cells. J Immunol 150:3459, 1993.
5) Cerf-Bensussan N, Guy-Grand D, Lisowska-Grospierre B, Griscelli C, Bhan AK:Amonoclonal antibody specific for rat intestinal lymphocytes. J Immunol 136:76, 1986.
12) Micklem KJ, Dong Y, Willis A, Pulford KA, Visser L, Durkop H, Poppema S, Stein H, Mason DY:HML-1 antigen on mucosa-associated T cells, activated cells, and hairy leukemic cells is a new integrin containing the beta 7 subunit. Am J Pathol 139:1297, 1991.
16) Schieferdecker HL, Ullrich R, Weiss-Breckwoldt AN, Schwarting R, Stein H, Riecken EO, Zeitz M:The HML-1 antigen of intestinal Iymphocytes is an activation antigen. J Immunol 144:2541, 1990.
17) Shaw SK, Cepek KL, Murphy EA, Russell GJ, Brenner MB, Parker CM:Molecular cloning of the human mucosal lymphocyte integrin alpha E subunit. Unusual structure and restricted RNA distribution. J Biol Chem 269:6016, 1994.
19) Spencer J, Cerf-Bensussan N, Jarry A, Brousse N, Guy-Grand D, Krajewski AS, Isaacson PG:Enteropathy-associated T cell lymphoma (malignant histiocytosis of the intestine) is recognized by a monoclonal antibody (HML-1) that defines a membrane molecule on human mucosal lymphocytes. Am J Pathol 132:1, 1988.
P.298 掲載の参考文献
8) Pulkkinen L, Kurtz K, Xu Y, Bruckner-Tuderman L, Uitto J:Genomic organization of the integrin beta 4gene (ITGB4):ahomozygous splice-site mutation in a patient with junctional epidermolysis bullosa associated with pyloric atresia. Lab In vest 76 (6):823-833, 1997.
P.300 掲載の参考文献
1) Letarte M, Greaves A, Vera S:In Leukocyte Typing V, (eds Schlossman SF, et al) , Oxford University Press, pp1756-1759, 1995.
3) Cheifetz S, Bellon T, Cales C, Vera S, Bernabeu C, Massague J, Letarte M:Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells. J Biol Chem 267:19027, 1992.
4) Gougos A, Letarte M:Identification of a human endothelial cell antigen with monoclonal antibody 44G4 produced against a pre-B leukemic cell line.J Immunol 141:1925, 1988.
5) Gougos A, Letarte M:Primary structure of endoglin, an RGD-containing glycoprotein of human endothelial cells. J Biol Chem 265:8361, 1990.
9) Quackenbush EJ, Letarte M:Identification of several cell surface proteins of non-T, non-B acute lymphoblastic leukemia by using monoclonal antibodies. J Immunol 134:1276, 1985.
10) Rokhlin OW, Cohen MB, Kubagawa H, Letarte M, Cooper MD:Differential expression of endoglin on fetal and adult hematopoietic cells in human bone marrow. J Immunol 154:4456, 1995.
P.301 掲載の参考文献
17) Hession C, Tizard R, Vassallo C, Schiffer SB, Goff D, Moy P, Chi-Rosso G, Luhowskyj S, Lobb R, Osborn L:Cloning of an alternate form of vascular cell adhesion molecule-1 (VCAM1) J Biol Chem 266 (11):6682-6685, 1991.
P.303 掲載の参考文献
P.305 掲載の参考文献
P.306 掲載の参考文献
1) Klickstein LB, Springer TA:CDw108 cluster report. In Leukocyte Typing V, (eds Schlossman SF, Boumsell L, Gilks W, Harlan JM, Kishimoto T, Morimoto C, Ritz J, Shaw S, Silverstein R, Springer T, Tedder TF, Todd RF) , Oxford University Press, p1477, 1995.
2) Bobolis KA, Lande WM, Telen MJ:Biochemical study of possible mechanisms of acquired loss of JMH antigen expression. Transfusion 31:46S, 1991.
3) Kubo K:ヒト活性化リンパ球に存在する新しいPIアンカー型蛋白 (Phosphatidylinositol anchored protein) の性状. J Kurume Med Assoc 12:1051-1060, 1991.
P.307 掲載の参考文献
10) Rappold I, Ziegler BL, Kohler I, Marchetto S, Rosnet O, Birnbaum D, Simmons PJ, Zannettino AC, Hill B, Neu S, Knapp W, Alitalo R, Alitalo K, Ullrich A, Kanz L, Buhring HJ:Functional and phenotypic characterization of cord blood and bone marrow subsets expressing FLT3 (CD135) receptor tyrosine kinase. Blood 90 (1):111-125, 1997.
P.309 掲載の参考文献
P.311 掲載の参考文献
P.312 掲載の参考文献
P.313 掲載の参考文献
1) Viprakasit V, Tachavanich K, Suwantol L, Pung-Amritt P, Chinchang W, Tanphaichitr VS:Allele related mutation specific-polymerase chain reaction for rapid diagnosis of Hb New York (beta 113 (G15) Val->Glu, beta (CD113 GTG->GAG). J Med Assoc Thai 85 (Suppl 2):S558-S563, 2002.
P.314 掲載の参考文献
1) Avalos BR:Molecular analysis of the granulocyte colony-stimulating factor receptor. Blood 88:761, 1996.
7) Kasper B, Hadam MR, Welte K:Detection of normal G-CSF receptor-proteins in patients with severe congenital neutropenia. Blood 86 (Suppl 1):510a, 1995.
P.317 掲載の参考文献
13) Hampe A, Shamoon BM, Gobet M, Sherr CJ, Galibert F:Nucleotide sequence and structural organization of the human FMS proto-oncogene. Oncogene Res 4 (1):9-17, 1989.
P.319 掲載の参考文献
10) Ronco LV, Silverman SL, Wong SG, Slamon DJ, Park LS, Gasson JC:Identification of conserved amino acids in the human granulocyte-macrophage colony-stimulating factor receptor alpha subunit critical for function. Evidence for formation of a heterodimeric receptor complex prior to ligand binding. J Biol Chem 269:277, 1994.
P.321 掲載の参考文献
1) Buhring, H-J, Ashman LK, Gattei V, Kniep B, Larregina A, Pinto A, Valent P, van den Oord JJ:In Leucocyte Typing V, (eds Schlossman SF, et al) , Oxford University Press, pp1882-1888, 1995.
7) Buhring HJ, Ullrich A, Schaudt K, Muller CA, Busch FW:The product of the proto-oncogene c-kit (P145c-kit) is a human bone marrow surface antigen of hemopoietic precursor cells which is expressed on a subset of acute non-lymphoblastic leukemic cells. Leukemia 5:854, 1991.
10) Hibi K, Takahashi T, Sekido Y, Ueda R, Hida T, Ariyoshi Y, Takagi H, Takahashi T:Coexpression of the stem cell factor and the c-kit genes in small-cell lung cancer. Oncogene 6:2291, 1991.
11) Lerner NB, Nocka KH, Cole SR, Qiu FH, Strife A, Ashman LK, Besmer P:Monoclonal antibody YB5. B8 identifies the human c-kit protein product. Blood 77:1876, 1991.
P.323 掲載の参考文献
P.325 掲載の参考文献
5) Eichholtz-Wirth H, Sagan D:Altered signaling of TNFalpha-TNFR1 and SODD/BAG4 is responsible for radioresistance in human HT-R15 cells. Anticancer Res 22 (1A):235-240, 2002.
13) Amrani Y, Ammit AJ, Panettieri RA Jr:Tumor necrosis factor receptor (TNFR) 1, but not TNFR2, mediates tumor necrosis factor-alpha-induced interleukin-6 and RANTES in human airway smooth muscle cells:role of p38 and p42/44 mitogen-activated protein kinases. Mol Pharmacol 60 (4):646-655, 2001.
P.329 掲載の参考文献
P.330 掲載の参考文献
P.332 掲載の参考文献
P.334 掲載の参考文献
P.336 掲載の参考文献
P.337 掲載の参考文献
3) Koike M, et al:In Leukocyte Typing VI, (eds Kishimoto T, et al), Garland Publishing Inc, New York, 1998. (in preparation)
P.339 掲載の参考文献
P.341 掲載の参考文献
P.343 掲載の参考文献
P.344 掲載の参考文献
P.345 掲載の参考文献
P.347 掲載の参考文献
1) Taga T, Kishimoto T:Gp130 and the interleukin-6 family of cytokines. Annu Rev Immunol 15:797, 1997.
P.349 掲載の参考文献
3) Hara T, Miyajima A:Two distinct functional high affinity receptors for mouse interleukin-3 (IL-3). EMBO J 11:1875, 1992.
P.352 掲載の参考文献
P.354 掲載の参考文献
P.356 掲載の参考文献
8) Baum PR, Gayle RB 3rd, Ramsdell F, Srinivasan S, Sorensen RA, Watson ML, Seldin MF, Clifford KN, Grabstein K, Alderson MR, et al:Identification of OX40 ligand and preliminary characterization of its activities on OX40 receptor. Circ Shock 44 (1):30-34, 1994. (No abstract available)
P.358 掲載の参考文献
1) Drexler HG:Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells. Leukemia 10:588, 1996.
8) Rappold I, Ziegler BL, Kohler I, Marchetto S, Rosnet O, Birnbaum D, Simmons PJ, Zannettino AC, Hill B, Neu S, Knapp W, Alitalo R, Alitalo K, Ullrich A, Kanz L, Buhring HJ:Functional and phenotypic characterization of cord blood and bone marrow subsets expressing FLT3 (CD135) receptor tyrosine kinase. Blood 90:111, 1997.
9) Rosnet O, Buhring HJ, Marchetto S, Rappold I, Lavagna C, Sainty D, Arnoulet C, Chabannon C, Kanz L, Hannum C, Birnbaum D:Human FLT3/FLK2 receptor tyrosine kinase is expressed at the surface of normal and malignant hematopoietic cells. Leukemia 10:238, 1996.
10) Rosnet O, Marchetto S, deLapeyriere O, Birnbaum D:Murine Flt3, a gene encoding a novel tyrosine kinase receptor of the PDGFR/CSFIR family. Oncogene 6:1641, 1991.
P.360 掲載の参考文献
2) Gaudino G, Avantaggiato V, Follenzi A, Acampora D, Simeone A, Comoglio PM:The proto-oncogene RON is involved in development of epithelial, bone and neuro-endocrine tissues. Oncogene 11:2627, 1995.
10) Ronsin C, Muscatelli F, Mattei MG, Breathnach R:A novel putative receptor protein tyrosine kinase of the met family. Oncogene 8:1195, 1993.
16) Wang MH, Montero-Julian FA, Dauny I, Leonard EJ:Requirement of phosphatidylinositol-3 kinase for epithelial cell migration activated by human macrophage stimulating protein. Oncogene 13:2167, 1996.
P.362 掲載の参考文献
P.364 掲載の参考文献
P.365 掲載の参考文献
1) Hadam MR:In Leukocyte Typing VI, section B35. (eds Kishimoto T, et al), Garland Publishing Inc, New York, 1998.
2) Grotjahn C, Heuring A, Lohmeyer J, Hadam MR:In Leukocyte Typing VI, section B28. 4/642, (eds Kishimoto T, et al), Garland Publishing Inc, New York, 1998.
3) Hardie DL, Hill DS, Casamayor M, van Lier R, Johnson GD, Khan M, MacLennan I:In Leukocyte Typing VI, section B28.6/644, (eds Kishimoto T, et al), Garland Publishing Inc, New York, 1998.
P.367 掲載の参考文献
6) Mosselman S, Claesson-Welsh L, Kamphuis JS, van Zoelen EJ:Developmentally regulated expression of two novel platelet-derived growth factor alpha-receptor transcripts in human teratocarcinoma cells. Cancer Res 54 (1):220-225, 1994.
P.368 掲載の参考文献
P.370 掲載の参考文献
9) Acebo E, Val-Bernal JF, Gomez-Roman JJ:Thrombomodulin, calretinin and c-kit (CD117) expression in cardiac myxoma. Histol Histopathol 16 (4):1031-1036, 2001.
P.372 掲載の参考文献
P.375 掲載の参考文献
1) Cambien F, Soubrier F:In Hypertension:Pathophysiology, Diagnosis, and Management, Second Edition, (eds Laragh JH, Brenner BM), Raven Press Ltd, New York, pp1667-1682, 1995.
3) Skidgel RA, Erdos EG:In The Renin Angiotensin System, Vol.1, (eds Robertson JIS, Nichols MG), Gower Medical Publ, London, pp10.1-10.10, 1993.
P.376 掲載の参考文献
P.377 掲載の参考文献
P.379 掲載の参考文献
4) George F, Mutin M, Laurent JC, Poncelet P, Sampol J:Antigenic densities defined by Workshop Endothelial Section mAb. In Leucocyte Typing V, (eds Schlossman SF, et al), Oxford University Press, Oxford 1848, PP1798-1801, 1995.
5) Lehmann JM, Holzmann B, Breitbart EW, Schmiegelow P, Riethmuller G, Johnson JP:Discrimination between benign and malignant cells of melanocytic lineage by two novel antigens, a glycoprotein with amolecular weight of 113,000 and a protein with a molecular weight of 76,000. Cancer Res 47:841, 1987.
8) Rummel MM, Sers C, Johnson JP:Phorbol ester and cyclic AMP-mediated regulation of the melanoma-associated cell adhesion molecule MUC18/MCAM. Cancer Res 56:2218, 1996.
10) Shih IM, Elder DE, Hsu MY, Herlyn M:Regulation of Mel-CAM/MUC18 expression on melanocytes of different stages of tumor progression by normal keratinocytes. Am J Pathol 145:837, 1994.
11) Shih IM, Kurman RJ:Expression of melanoma cell adhesion molecule in intermediate trophoblast. Lab Invest 75:377, 1996.
P.381 掲載の参考文献
2) Biswas C, Zhang Y, DeCastro R, Guo H, Nakamura T, Kataoka H, Nabeshima K:The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily. Cancer Res 55:434, 1995.
9) Schiavone EM, Tortora V, Armetta I, Bontempo P, Mosti MR, Pezone L, Nola E, Puca, GA, Vacca C, Molinari AM:CD147 workshop:expression, modulation, and involvement in homotypic aggregation and adhesion to matrix of molecules recognized by monoclonal antibodies to CD147 on breast cancer cell lines. In Leukocyte Typing VI, (eds Kishimoto T, et al), Garland Publishing Inc, New York, pp764-765, 1997.
12) Stockinger H, Ebel T, Hansmann C, Koch C, Majdic O, Prager E, Patel DD, Fox DA, Horejsi V, Sagawa K, Shen D:CD147 (neurothelin/basigin) workshop panel report. In Leucocyte Typing VI, (eds Kishimoto T, et al), Garland Publishing Inc, New York, pp760-763, 1997.
P.382 掲載の参考文献
P.385 掲載の参考文献
P.387 掲載の参考文献
2) Ashman LK, Fitter S, Sincock PM, Nguyen L, Cambareri AC:In Leukocyte Typing VI, (eds Kishimoto T, et al), Garland Publishing Inc, New York, this volume PL14, 1998.
3) Cole SR, Kriek GW, Ashman LK:In Leucocyte Typing IV, (eds Knapp W, et al), Oxford University Press, pp991-992, 1989.
4) Ferro LM, Fitter S, Tetaz TJ, Berndt MC, Ashman LK:In Leucocyte Typing V, (eds Schlossman SF, et al), Oxford University Press, pp1244-1245, 1995.
8) von dem Borne, Kr A E G:In Leucocyte Typing IV, (eds Knapp W, et al), Oxford University Press, pp1044-1045, 1989.
P.388 掲載の参考文献
P.390 掲載の参考文献
P.392 掲載の参考文献
P.394 掲載の参考文献
P.395 掲載の参考文献
P.397 掲載の参考文献
P.399 掲載の参考文献
11) Todd RF 3d, Roach JA, Arnaout MA:The modulated expression of Mo5, a human myelomonocytic plasma membrane antigen. Blood 65:964, 1985.
P.403 掲載の参考文献
3) Parham P:NK cells, MHC class I antigens and missing self. Immunol Rev 155:5-221, 1997.
15) Carretero et al:In Leucocyte typing VI, (eds Kishimoto T, et al), Garland Publishing Inc, New York &London, P294, 1998.
22) Dohring C, Samaridis J, Colonna M:Alternatively spliced forms of human killer inhibitory receptors. Immunogenetics 44:227, 1996.
35) Lazetic S, Chang C, Houchins JP, Lanier LL, Phillips JH:Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits. J Immunol 157:4741, 1996.
P.407 掲載の参考文献
P.409 掲載の参考文献
P.410 掲載の参考文献
P.412 掲載の参考文献
P.413 掲載の参考文献
P.414 掲載の参考文献
P.415 掲載の参考文献
P.417 掲載の参考文献
P.418 掲載の参考文献
2) Bowen MA, Patel DD, Li X, Modrell B, Malacko AR, Wang WC, Marquardt H, Neubauer M, Pesando JM, Francke U, et al:Cloning, mapping, and characterization of activated leukocyte-cell adhesion molecule (ALCAM), a CD6 ligand. J Exp Med 181:2213, 1995.
P.421 掲載の参考文献
5) Perez JL, Jing SQ, Wong TW:Identification of two isoforms of the Cak receptor kinase that are coexpressed in breast tumor cell lines. Oncogene 12 (7):1469-1477, 1996.
7) Perez JL, Shen X, Finkernagel S, Sciorra L, Jenkins NA, Gilbert DJ, Copeland NG, Wong TW:Identification and chromosomal mapping of a receptor tyrosine kinase with a putative phospholipid binding sequence in its ectodomain. Oncogene 9 (1):211-219, 1994.
9) Laval S, Butler R, Shelling AN, Hanby AM, Poulsom R, Ganesan TS:Isolation and characterization ofan epithelial-specific receptor tyrosine kinase from an ovarian cancer cell line. Cell Growth Differ 5 (11):1173-1183, 1994.
P.422 掲載の参考文献
P.423 掲載の参考文献
P.426 掲載の参考文献
P.427 掲載の参考文献
P.429 掲載の参考文献
P.432 掲載の参考文献
P.434 掲載の参考文献
P.435 掲載の参考文献
1) Nakagoe T, Fukushima K, Itoyanagi N, Ikuta Y, Oka T, Nagayasu T, Ayabe H, Hara S, Ishikawa H, Minami H:Expression of ABH/Lewis-related antigens as prognostic factors in patients with breast cancer. J Cancer Res Clin Oncol 128 (5):257-264, 2002.
P.436 掲載の参考文献
P.437 掲載の参考文献
P.438 掲載の参考文献
P.439 掲載の参考文献
P.442 掲載の参考文献
P.444 掲載の参考文献
P.445 掲載の参考文献
P.446 掲載の参考文献
P.449 掲載の参考文献
P.451 掲載の参考文献
9) Taichman RS, Cooper C, Keller ET, Pienta KJ, Taichman NS, McCauley LK:Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone. Cancer Res 62 (6):1832-1837, 2002.
P.454 掲載の参考文献
P.456 掲載の参考文献
P.458 掲載の参考文献
P.459 掲載の参考文献
P.461 掲載の参考文献
9) Ziegler SF, Bird TA, Schneringer JA, Schooley KA, Baum PR:Molecular cloning and characterization of a novel receptor protein tyrosine kinase from human placenta. Oncogene 8 (3):663-670, 1993.
P.463 掲載の参考文献
P.464 掲載の参考文献
P.465 掲載の参考文献
P.468 掲載の参考文献
P.469 掲載の参考文献
P.470 掲載の参考文献
2) Ozaki K, Nagata M, Suzuki M, Fujiwara T, Ueda K, Miyoshi Y, Takahashi E, Nakamura Y:Isolation and characterization of a novel human lung-specific gene homologous to lysosomal membrane glyco-proteins 1 and 2:significantly increased expression in cancers of various tissues. Cancer Res 58 (16):3499-3503, 1998.
P.472 掲載の参考文献
P.473 掲載の参考文献
P.475 掲載の参考文献
P.477 掲載の参考文献
P.479 掲載の参考文献
P.480 掲載の参考文献
P.482 掲載の参考文献
14) Cocozza S, Porcellini A, Riccardi G, Monticelli A, Condorelli G, Ferrara A, Pianese L, Miele C, Capaldo B, Beguinot F, et al:NIDDM associated with mutation in tyrosine kinase domain of insulin receptor gene. Diabetes 41 (4):521-526, 1992.
P.484 掲載の参考文献
1) Watanabe H, Yu D, Sasaki T, Shibuya H, Hosoi Y, Asada M, Komatsu K, Miura M:Insulin-like growth factor I receptor is expressed at normal levels in Nijmegen breakage syndrome cells. Biochenz Biophys Res Commun 296 (1):62-66, 2002.
4) de Mello Coelho V, Villa-Verde DM, Farias-de-Oliveira DA, de Brito JM, Dardenne M, Savino W:Functional insulin-like growth factor-1/insulin-like growth factor-1 receptor-mediated circuit in human and murine thymic epithelial cells. Neuroendocrinology 75 (2):139-150, 2002.
5) Chakravarti A, Loeffler JS, Dyson NJ:Insulin-like growth factor receptor 1 mediates resistance to anti-epidermal growth factor receptor therapy in primary human glioblastoma cells through continued activation of phosphoinositide 3-kinase signaling. Cancer Res 62 (1):200-207, 2002.
P.486 掲載の参考文献
10) De Souza AT, Hankins GR, Washington MK, Fine RL, Orton TC, Jirtle RL:Frequent loss of heter-ozygosity on 6q at the mannose 6-hosphate/insulin-like growth factor ll receptor locus in human hepatocellular tumors. Oncogene 10 (9):1725-1729, 1995.
P.488 掲載の参考文献
P.489 掲載の参考文献
7) Sakamuro D, Yamazoe M, Matsuda Y, Kangawa K, Taniguchi N, Matsuo H, Yoshikawa H, Ogasawara N:The primary structure of human gamma-glutamyl transpeptidase. Gene 73 (1):1-9, 1988.
P.492 掲載の参考文献
P.493 掲載の参考文献
P.495 掲載の参考文献
4) Porowska H, Paszkiewicz-Gadek A, Wolczynski S, Gindzienski A:MUC1 expression in human breast cancer cells is altered by the factors affecting cell proliferation. Neoplasma 49 (2):104-109, 2002.
12) Baldus SE, Hanisch FG, Putz C, Flucke U, Monig SP, Schneider PM, Thiele J, Holscher AH, Dienes HP:Immunoreactivity of Lewis blood group and mucin peptide core antigens:correlations with grade of dysplasia and malignant transformation in the colorectal adenoma-carcinoma sequence. Histol Histopathol 17 (1):191-198, 2002.
P.497 掲載の参考文献
P.498 掲載の参考文献
P.500 掲載の参考文献
P.501 掲載の参考文献
P.503 掲載の参考文献
P.505 掲載の参考文献
2) Inaba M:Band 3:expanding knowledge on its functions. Seikagaku 73 (12):1431-1435, 2001. (Japanese)
3) Tanner MJ:Molecular and cellular biology of the erythrocyte anion exchanger (AE1). Semin Hematol 30 (1):34-57, 1993.
P.507 掲載の参考文献
2) Woolley IJ, Kalayjian R, Valdez H, Hamza N, Jacobs G, Lederman MM, Zimmerman PA:HIV nephropathy and the Duffy antigen/receptor for Chemokines in African Americans. J Nephrol 14 (5):384-387, 2001.
P.509 掲載の参考文献
1) Johnson ST, McFarland JG, Kelly KJ, Casper JT, Gottschall JL:Transf
P.510 掲載の参考文献
P.513 掲載の参考文献
P.514 掲載の参考文献
P.516 掲載の参考文献
P.517 掲載の参考文献
2) Campbell IG, Foulkes WD, Senger G, Trowsdale J, Garin-Chesa P, Rettig WJ:Molecular cloning of the B-CAM cell surface glycoprotein of epithelial cancers:a novel member of the immunoglobulin super-family. Cancer Res 54 (22):5761-5765, 1994.
3) Parsons SF, Mallinson G, Holmes CH, Houlihan JM, Simpson KL, Mawby WJ, Spurr NK, Warne D, Barclay AN, Anstee DJ:The Lutheran blood group glycoprotein, another member of the immunoglobulin superfamily, is widely expressed in human tissues and is developmentally regulated in human liver. Proc Natl Acad Sci USA 92 (12):5496-5500, 1995.
P.518 掲載の参考文献
1) Flegel WA, Wagner FF:Molecular genetics of RH. Vox Sang 78 (Suppl 2):109-115, 2000.
9) Huang CH, Chen Y, Reid M, Ghosh S:Genetic recombination at the human RH locus:afamily study of the red-cell Evans phenotype reveals a transfer of exons 2-6 from the RHD to the RHCE gene. Am J Hum Genet 59 (4):825-833, 1996.
P.520 掲載の参考文献
P.522 掲載の参考文献
P.524 掲載の参考文献
P.525 掲載の参考文献
1) Illmer T, Schuler US, Thiede C, Schwarz UI, Kim RB, Gotthard S, Freund D, Schakel U, Ehninger G, Schaich M:MDR1 gene polymorphisms affect therapy outcome in acute myeloid leukemia patients. Cancer Res 62 (17):4955-4962, 2002.
3) Galani E, Sgouros J, Petropoulou C, Janinis J, Aravantinos G, Dionysiou-Asteriou D, Skarlos D, Gonos E:Correlation of MDR-1, nm23-H1 and H Sema E gene expression with histopathological findings and clinical outcome in ovarian and breast cancer patients. Anticancer Res 22 (4):2275-2280, 2002.
6) Tafuri A, Gregorj C, Petrucci MT, Ricciardi MR, Mancini M, Cimino G, Mecucci C, Tedeschi A, Fioritoni G, Ferrara F, Di Raimondo F, Gallo E, Liso V, Fabbiano F, Cascavilla N, Pizzolo G, Camera A, Pane F, Lanza F, Cilloni D, Annino L, Vitale A, Vegna ML, Vignetti M, Foa R, Mandelli F:MDR1 protein expression is an independent predictor of complete remission in newly diagnosed adult acute lymphoblastic leukemia. Blood 100 (3):974-981, 2002.
16) Potocnik U, Ravnik-Glavac M, Glavac D:Functional MDR1 polymorphisms (G2677T and C3435T) and TCF4 mutations in colorectal tumors with high microsatellite instability. Cell Mol Biol Lett 7 (1):92-95, 2002.
19) Kucerova H, Sumerauer D, Drahokoupilova E, Piskova M, Bedrnicek J, Eckschlager T:Significance of P-glycoprotein expression in childhood malignant tumors. Neoplasma 48 (6):472-478, 2001.
P.527 掲載の参考文献
7) Tangye SG, Lazetic S, Woollatt E, Sutherland GR, Lanier LL, Phillips JH:Cutting edge:human 2B4, an activating NK cell receptor, recruits the protein tyrosine phosphatase SHP-2 and the adaptor signaling protein SAP. J Immunol 162 (12):6981-6985, 1999.
P.529 掲載の参考文献
1) Okumura K, Kato K, Kobata T:T-cell antigens:section report. In Leukocyte Typing VI, (eds Kishimoto T, et al), Garland Publishing Inc, New York, pp23-32, 1998.
P.530 掲載の参考文献
P.532 掲載の参考文献
12) Jensen JP, Hou D, Ramsburg M, Taylor A, Dean M, Weissman AM:Organization of the human T cell receptor zeta/eta gene and its genetic linkage to the Fc gamma RII-Fc gamma RIII gene cluster. J Immuunol 148 (8):2563-2571, 1992.

最近チェックした商品履歴

Loading...